Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder

TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

New Wave Holdings Corp Appoints Dr. Wade Davis to Psychedelic Research Advisory Board

TORONTO, Aug. 31, 2020 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company”…

Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics

Developed Prototypes of Orally Dissolvable Thin Film For Psilocybin TORONTO, Aug. 11,…

A Blooming Opportunity For Investors To Cash In On Mushroom Stocks

Once A Fringe Industry Now Being Called The Biggest Opportunity Since Legal Cannabis

Are Mushroom Penny Stocks Next To Boom After This $27M Bet?

Whether You Call Them Psychedelic Stocks, Shroom Stocks, Or Psilocybin Stocks, These Are Gaining Attention Right Now

Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

TORONTO, June 12, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

3 Penny Stocks To Watch Under $1 Right Now

Penny Stocks Trading Under $1; Are They On Your List This Month?…